Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aveanna Healthcare Holdings (AVAH) Enterprise Value (2021 - 2026)

Aveanna Healthcare Holdings' Enterprise Value history spans 6 years, with the latest figure at -$201.9 million for Q1 2026.

  • For Q1 2026, Enterprise Value fell 64.72% year-over-year to -$201.9 million; the TTM value through Jan 2026 reached -$201.9 million, down 64.72%, while the annual FY2026 figure was -$201.9 million, 64.72% down from the prior year.
  • Enterprise Value reached -$201.9 million in Q1 2026 per AVAH's latest filing, down from -$160.4 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$30.5 million in Q1 2022 to a low of -$201.9 million in Q1 2026.
  • Average Enterprise Value over 5 years is -$108.7 million, with a median of -$105.1 million recorded in 2024.
  • The largest YoY upside for Enterprise Value was 77.8% in 2022 against a maximum downside of 231.15% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$101.0 million in 2022, then rose by 3.51% to -$97.4 million in 2023, then decreased by 25.82% to -$122.6 million in 2024, then plummeted by 30.88% to -$160.4 million in 2025, then decreased by 25.86% to -$201.9 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Enterprise Value are -$201.9 million (Q1 2026), -$160.4 million (Q3 2025), and -$121.4 million (Q2 2025).